L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
PKvitality is developing K'Watch Glucose, a painless Continuous Glucose Monitoring device in a form of a smartwatch. Completely invisible to others, K'Watch will help diabetics to better control their disease and check their glucose level discreetly.
Le Kremlin-Bicêtre, Île-de-France, France
Send a message
Paris, November 25, 2019 –PKvitality, a French company specialized in MedTechdeveloping a CGM smartwatch, announces the creation of its advisory board, consisting of John Brooks, the creator of tubeless insulin pump and Alexandre Richard, the director of corporate M&A at Sanofi.
Paris, November 25, 2019 – Pkvitality, a French company specialized in MedTech, has joined Dassault Systèmes' 3DEXPERIENCE Lab Program, making Dassault Systèmes its official partner for IT applications for the development of K'Watch project, a Continuous Glucose Monitor (CGM) in a form of a smartwatch.
Paris, December 04, 2019 – PKvitality, a French company specialized in bio wearables, was awarded first position in Medtech category in European Health Catapult held on 2 and 3 December 2019 at Paris.PKvitality is currently working on the development of K'Watch project, a Continuous Glucose Monitor(CGM) in a form of a smartwatch.
Start in 2016
First results of in vivo tests on pigs
CES presence: 6 awards including 1 BEST OF INNOVATION in "Tech for a better world" category
K'Watch announced as a Continuous Glucose Monitoring device
Entering Series A fundraising tour with MedTech and BioTech showcases at San Francisco
to be continued ...